首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 主要藥物給藥企業的開發動向
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

主要藥物給藥企業的開發動向

Who's Developing What in Drug Delivery?

出版商 Espicom Business Intelligence
出版日期 2009年11月 商品編碼 103589
內容資訊 英文 Pages: 680
價格
US $ 1040 Hard Copy
US $ 1040 PDF by E-mail (Single user license)
US $ 1040 Web Access (Single user license)


主要藥物給藥企業的開發動向 是由出版商Espicom Business Intelligence在2009年11月所出版的。 這份英文市場調查報告書包含Pages: 680 價格從美金1040起跳。

簡介

本報告書內容包括:全球18個國家,130家藥物給藥公司的企業概要和計劃的調査分析、企業檔案、主要技術・產品的概要、人事動向、R&D・研究戰略、契約・結盟動向、財務檔案等的彙整、內容綱要摘記如下:

調査内容

  • 企業概要和技術
  • 主要職員・人事
  • 競爭及競爭產品
  • 主要的里程碑
  • 產品/技術
  • R&D・研究戰略
  • 主要契約和結盟
  • 財務檔案
  • 連繫資訊

主要技術

  • 控釋性給藥
  • 核酸給藥
  • 奈米給藥
  • 靶向給藥

目錄

Abstract

The indispensible 2-volume guide to the companies that are shaping this critical area.

The importance of drug delivery technology grows ever more acute and commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, and bring new therapies to the market that would, previously, have been impossible to administer.

Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable.

The credit crunch has taken its toll, but investors are returning

Many drug delivery development companies have been hit hard by the recession. With investor capital in short supply to fund technology developments, many smaller companies have failed. Positively, there have been signs on the horizon that investors are returning to the sector, but investment is more focused on innovative technologies that have a good chance of achieving commercial returns.

Key features and benefits...

  • Detailed review of 130 leading companies in the field
  • Comprehensive coverage of each company' s technology focus, products, R&D and deals
  • International coverage - companies from 18 countries reviewed
  • All major drug-delivery technologies covered including:
    • Controlled-release
    • Nucleic acid
    • Nano-enabled
    • Targeted
  • Available in feature-rich web, pdf or print editions

Table of Contents

Part - 1

  • 3M DRUG DELIVERY SYSTEMS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ABRAXIS BIOSCIENCE INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • RELATED COMPANIES
  • ACCESS PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • PRODUCTS / TECHNOLOGIES (Macrochem)
    • RESEARCH ACTIVITIES
    • RESEARCH ACTIVITIES (Macrochem)
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACUSPHERE INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACRUX LTD.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • AKELA PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • RESEARCH ACTIVITIES
    • TECHNOLOGIES/PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALKERMES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ALPHARX INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • ALPHAVAX INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALTEA THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ANTARES PHARMA INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • AP PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ARADIGM CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ARCHIMEDES PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • BAXA CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • BAXTER INTERNATIONAL INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIODELIVERY SCIENCES INTERNATIONAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • BIOJECT MEDICAL TECHNOLOGIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOSANTE PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOVAIL CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • CALANDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CAMURUS AB
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CAREFUSION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • KEY FINANCIAL DATA
    • COMPETITION
  • CELATOR PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • R&D ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CELL THERAPEUTICS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CEPHALON
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • R&D ACTIVITIES
    • AGREEMENTS
    • CIMA AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CIPHER PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/PRODUCTS
    • R&D MILESTONES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • COLUMBIA LABORATORIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CONSORT MEDICAL PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • COPERNICUS THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CORNERSTONE THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CPEX PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CYDEX PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • DEBIOPHARM SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DELCATH SYSTEMS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DEPOMED INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DIATOS SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DURECT CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • DUSA PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ECHO THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ELAN CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ELITE PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • EMISPHERE TECHNOLOGIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ENCAP DRUG DELIVERY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • KEY MILESTONES (INDEVUS)
    • TECHNOLOGIES/PRODUCTS
    • PRODUCTS (INDEVUS)
    • R&D MILESTONES
    • RESEARCH ACTIVITIES (INDEVUS)
    • AGREEMENTS
    • AGREEMENTS (INDEVUS)
    • COMPETITION
    • KEY FINANCIAL DATA
  • ENDOCYTE
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENZON INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • EPEIUS BIOTECHNOLOGIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS/TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
    • COMPETITION
  • ETHYPHARM S/A
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EURAND
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EXPRESSION GENETICS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • FERTIN PHARMA A/S
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • R&D ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • FLAMEL TECHNOLOGIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • FZIOMED INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GENEREX BIOTECHNOLOGY CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • GILEAD SCIENCES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GLYCOLOGIC LTD.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • HOSPIRA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • IKANO THERAPEUTICS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • IMARX THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • IMMUNOGEN
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • IMPAX LABORATORIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INNOCOLL TECHNOLOGIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • INOVIO BIOMEDICAL INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES / PRODUCTS
    • TECHNOLOGIES / PRODUCTS (VGX PHARMACEUTICALS)
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • KEY COMPETITORS
  • INSITE VISION INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INTELGENX CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INTERCELL AG
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • INTERCELL KEY MILESTONES
    • INTERCELL PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES (INTERCELL)
    • RESEARCH ACTIVITIES (IOMAI)
    • AGREEMENTS (INTERCELL)
    • AGREEMENTS (IOMAI)
    • KEY FINANCIAL DATA
    • COMPETITION

List of companies:

  • 3M DRUG DELIVERY SYSTEMS
  • ABRAXIS BIOSCIENCE INC.
  • ACCESS PHARMACEUTICALS INC.
  • ACUSPHERE INC.
  • ACRUX LTD.
  • AKELA PHARMA
  • ALKERMES INC.
  • ALPHARX INC.
  • ALPHAVAX INC.
  • ALTEA THERAPEUTICS
  • ANTARES PHARMA INC.
  • AP PHARMA INC.
  • ARADIGM CORPORATION
  • ARCHIMEDES PHARMA
  • Baxa Corporation
  • BAXTER INTERNATIONAL INC.
  • BIODELIVERY SCIENCES INTERNATIONAL
  • BIOJECT MEDICAL TECHNOLOGIES INC.
  • BIOSANTE PHARMACEUTICALS INC.
  • BIOVAIL CORPORATION
  • CALANDO PHARMACEUTICALS
  • CAMURUS AB
  • CAREFUSION
  • CELATOR PHARMACEUTICALS INC.
  • CELL THERAPEUTICS INC.
  • CEPHALON
  • CIPHER PHARMACEUTICALS
  • COLUMBIA LABORATORIES INC.
  • CONSORT MEDICAL PLC
  • COPERNICUS THERAPEUTICS
  • CORNERSTONE THERAPEUTICS
  • CPEX PHARMACEUTICALS INC.
  • CYDEX PHARMACEUTICALS
  • DEBIOPHARM SA
  • DELCATH SYSTEMS INC.
  • DEPOMED INC.
  • DIATOS SA
  • DURECT CORPORATION
  • DUSA PHARMACEUTICALS INC.
  • ECHO THERAPEUTICS
  • ELAN CORPORATION
  • ELITE PHARMACEUTICALS INC.
  • EMISPHERE TECHNOLOGIES INC.
  • ENCAP DRUG DELIVERY
  • ENDO PHARMACEUTICALS
  • ENDOCYTE
  • ENZON INC.
  • EPEIUS BIOTECHNOLOGIES INC.
  • ETHYPHARM S/A
  • EURAND
  • EXPRESSION GENETICS INC.
  • FERTIN PHARMA A/S
  • FLAMEL TECHNOLOGIES INC.
  • FZIOMED INC.
  • GENEREX BIOTECHNOLOGY CORPORATION
  • GILEAD SCIENCES
  • GLYCOLOGIC LTD.
  • HOSPIRA
  • IKANO THERAPEUTICS INC.
  • ImaRx THERAPEUTICS
  • IMMUNOGEN
  • IMPAX LABORATORIES
  • INNOCOLL TECHNOLOGIES
  • INOVIO BIOMEDICAL INC.
  • INSITE VISION INC.
  • INTELGENX CORPORATION
  • INTERCELL AG

Part - 2

  • KV PHARMACEUTICAL COMPANY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • LABOPHARM INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • LAVIPHARM GROUP
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • LIGHT SCIENCES CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • MANNKIND CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MAXCYTE INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • MDRNA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MEDIMMUNE INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MELDEX INTERNATIONAL PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MILESTONE SCIENTIFIC
    • KEY PERSONNEL
    • COMPANY BACKGROUND
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MOOG MEDICAL DEVICES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOBIOTIX
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOMATERIALS TECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOBIO CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • NANOBIOMAGNETICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOCARRIER
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOTHERAPEUTICS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANO INTERFACE TECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • NANO S BIOTECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVIties
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOVENTURES AUSTRALIA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED ACTIVITIES
  • NEKTAR THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • NEOPHARM INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NEXMED INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NEUROTECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • NOVADEL PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NOVAGALI PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NOVAVAX
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NOVEN PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NOVOSOM AG
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OAKWOOD LABORATORIES LLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OCTOPLUS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OREXO
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • OTSUKA PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PACIRA PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • PCI BIOTECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PENWEST PHARMACEUTICALS COMPANY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • FINANCIALS
    • COMPETITION
  • PHOSPHAGENICS LIMITED
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES / PRODUCTS
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • FINANCIALS
  • PHOTOCURE ASA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • POLYTHERICS LTD.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PSIVIDA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES / PRODUCTS
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • QLT
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • QUEST PHARMATECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • RAPTOR PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • RETRACTABLE TECHNOLOGIES INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • SAVARA PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • KEY FINANCIAL DATA
  • SCOLR PHARMA INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • SEATTLE GENETICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SILENCE THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SKINVISIBLE INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH activities
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • SKYEPHARMA PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • SOLIGENIX
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • STARPHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SUPRATEK PHARMA INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • TEKMIRA PHARMACEUTICALS CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • TELESSO TECHNOLOGIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • TRANSDEL PHARMACEUTICALS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • COMPETITION
    • KEY FINANCIAL DATA
  • TRANSPHARMA MEDICAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • URIGEN PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • VECTURA LTD.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • VICAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • VIVUS INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ZOGENIX INC.
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ZOSANO PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA

List of companies:

  • KV PHARMACEUTICAL COMPANY
  • LABOPHARM INC.
  • LAVIPHARM GROUP
  • LIGHT SCIENCES CORPORATION
  • MANNKIND CORPORATION
  • MAXCYTE INC.
  • MDRNA
  • MEDIMMUNE INC.
  • MELDEX INTERNATIONAL PLC
  • MILESTONE SCIENTIFIC
  • MOOG MEDICAL DEVICES
  • NANOBIOTIX
  • NANOMATERIALS TECHNOLOGY
  • NANOBIO CORPORATION
  • NANOBIOMAGNETICS
  • NANOCARRIER
  • NANOTHERAPEUTICS INC.
  • NANO INTERFACE TECHNOLOGY
  • NANO S BIOTECHNOLOGY
  • NANOVENTURES AUSTRALIA
  • NEKTAR THERAPEUTICS
  • NEOPHARM INC.
  • NEXMED INC.
  • NEUROTECH
  • NOVADEL PHARMA
  • NOVAGALI PHARMA
  • NOVAVAX
  • NOVEN PHARMACEUTICALS
  • NOVOSOM AG
  • OAKWOOD LABORATORIES LLC
  • OCTOPLUS
  • OREXO
  • OTSUKA PHARMA
  • PACIRA PHARMACEUTICALS INC.
  • PCI BIOTECH
  • PENWEST PHARMACEUTICALS COMPANY
  • PHOSPHAGENICS LIMITED
  • PHOTOCURE ASA
  • POLYTHERICS LTD.
  • pSivida
  • QLT
  • QUEST PHARMATECH
  • RAPTOR PHARMACEUTICALS
  • RETRACTABLE TECHNOLOGIES INC.
  • SAVARA PHARMACEUTICALS INC.
  • SCOLR PHARMA INC.
  • SEATTLE GENETICS
  • SILENCE THERAPEUTICS
  • SKINVISIBLE INC.
  • SKYEPHARMA PLC
  • SOLIGENIX
  • STARPHARMA
  • SUPRATEK PHARMA INC.
  • TEKMIRA PHARMACEUTICALS CORPORATION
  • TELESSO TECHNOLOGIES
  • TRANSDEL PHARMACEUTICALS INC.
  • TRANSPHARMA MEDICAL
  • URIGEN PHARMACEUTICALS
  • VECTURA LTD.
  • VICAL
  • VIVUS INC.
  • ZOGENIX INC.
  • ZOSANO PHARMA
Back to Top